CareDx to Participate in Upcoming Investor Conferences

News > Business News

Audio By Carbonatix

7:05 AM on Tuesday, November 12, 2024

The Associated Press

BRISBANE, Calif.--(BUSINESS WIRE)--Nov 12, 2024--

CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in the following investor conferences.

Jefferies London Healthcare Conference 2024 in London, UK. Presentation on Tuesday, November 19 at 9:00 AM GMT/4:00 AM EST
Stephens Investment Conference (NASH2024 ) in Nashville, TN. Fireside chat on Thursday, November 21 at 8:00 AM CST/9:00 AM EST
Piper Sandler Healthcare Conference in New York, NY. Presentation on Wednesday, December 4 at 10:10 AM EST

To listen to the webcast, please visit the Events & Presentations section of CareDx’s Investor Relations website at: investors.caredx.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20241112543765/en/

CONTACT: CareDx, Inc.

Media Relations

Anna Czene

818-731-2203

[email protected]

Investor Relations

Greg Chodaczek

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: GENERAL HEALTH HEALTH SURGERY

SOURCE: CareDx, Inc.